Skip to main content
Erschienen in: International Urology and Nephrology 8/2017

26.05.2017 | Urology - Original Paper

Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004–2013

verfasst von: Kyle Plante, Telisa M. Stewart, Dongliang Wang, Gennady Bratslavsky, Margaret Formica

Erschienen in: International Urology and Nephrology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

To provide updated treatment trends, determinants, and survival of partial nephrectomy (PN) and radical nephrectomy (RN) across the USA.

Data sources

Secondary data from the National Cancer Data Base (NCDB) participant user file from 2004 to 2013. The NCDB captures approximately 70% of all newly diagnosed cancer cases each year.

Study design

Multivariable logistic regression was used to estimate odds ratios for RN overall. Kaplan–Meier, multivariable Cox regression, and log-rank test were used to characterize patient survival.

Data collection

Patients diagnosed with clinical stage I RCC who received either RN or PN as the primary surgical treatment were included.

Principle findings

The study consisted of 121,386 cases (PN = 57,016; RN = 64,370). The overall use of PN for stage I RCC increased by 24.2% over 9 years. An overall 5- and 10-year survival advantage was estimated following PN compared to RN; estimated overall risk of death was higher with RN.

Conclusions

The use of PN for stage I RCC has continued to increase and is associated with an overall survival advantage. Multivariable analysis showed that disparities exist among sociodemographic groups that are also associated with treatment type and survival.
Literatur
4.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. JURO 182:1271–1279. doi:10.1016/j.juro.2009.07.004 Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. JURO 182:1271–1279. doi:10.​1016/​j.​juro.​2009.​07.​004
6.
Zurück zum Zitat Belldegrun A, Tsui KH, deKernion JB, Smith RB (1999) Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17:2868–2875CrossRefPubMed Belldegrun A, Tsui KH, deKernion JB, Smith RB (1999) Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17:2868–2875CrossRefPubMed
11.
Zurück zum Zitat Liss MA, Wang S, Palazzi K, Jabaji R, Patel N, Lee HJ, Parsons JK, Derweesh IH (2014) Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 14:101. doi:10.1186/1471-2490-14-101 CrossRefPubMedPubMedCentral Liss MA, Wang S, Palazzi K, Jabaji R, Patel N, Lee HJ, Parsons JK, Derweesh IH (2014) Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 14:101. doi:10.​1186/​1471-2490-14-101 CrossRefPubMedPubMedCentral
12.
13.
Zurück zum Zitat Weight CJ, Lieser G, Larson BT, Gao T, Lane BR, Campbell SC, Gill IS, Novick AC, Fergany AF (2010) Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 58:293–298. doi:10.1016/j.eururo.2010.04.033 CrossRefPubMed Weight CJ, Lieser G, Larson BT, Gao T, Lane BR, Campbell SC, Gill IS, Novick AC, Fergany AF (2010) Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 58:293–298. doi:10.​1016/​j.​eururo.​2010.​04.​033 CrossRefPubMed
14.
Zurück zum Zitat Weight CJ, Crispen PL, Breau RH, Kim SP, Lohse CM, Boorjian SA, Thompson RH, Leibovich BC (2013) Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int 111:731–738. doi:10.1111/j.1464-410X.2012.11112.x CrossRefPubMed Weight CJ, Crispen PL, Breau RH, Kim SP, Lohse CM, Boorjian SA, Thompson RH, Leibovich BC (2013) Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int 111:731–738. doi:10.​1111/​j.​1464-410X.​2012.​11112.​x CrossRefPubMed
15.
Zurück zum Zitat Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179:468–471. doi:10.1016/j.juro.2007.09.077 CrossRefPubMed Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179:468–471. doi:10.​1016/​j.​juro.​2007.​09.​077 CrossRefPubMed
16.
17.
Zurück zum Zitat Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Colombel M, Klotz L, Skinner E, Keane T, Marreaud S, Collette S, Sylvester R (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552. doi:10.1016/j.eururo.2010.12.013 CrossRefPubMed Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Colombel M, Klotz L, Skinner E, Keane T, Marreaud S, Collette S, Sylvester R (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552. doi:10.​1016/​j.​eururo.​2010.​12.​013 CrossRefPubMed
18.
Zurück zum Zitat Mohanty S, Bilimoria KY (2014) Comparing national cancer registries: the National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J Surg Oncol 109:629–630. doi:10.1002/jso.23568 CrossRefPubMed Mohanty S, Bilimoria KY (2014) Comparing national cancer registries: the National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J Surg Oncol 109:629–630. doi:10.​1002/​jso.​23568 CrossRefPubMed
22.
Zurück zum Zitat Daugherty M, Bratslavsky G (2014) Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (???4 cm): an analysis of the SEER database. Urol Oncol Semin Orig Investig. doi:10.1016/j.urolonc.2013.11.009 Daugherty M, Bratslavsky G (2014) Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (???4 cm): an analysis of the SEER database. Urol Oncol Semin Orig Investig. doi:10.​1016/​j.​urolonc.​2013.​11.​009
Metadaten
Titel
Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004–2013
verfasst von
Kyle Plante
Telisa M. Stewart
Dongliang Wang
Gennady Bratslavsky
Margaret Formica
Publikationsdatum
26.05.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 8/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1612-0

Weitere Artikel der Ausgabe 8/2017

International Urology and Nephrology 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.